Eisai Co - Company & Market Research Reports

Home /
Companies /
Eisai Co

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 121
Oncology Drugs 107
Gastrointestinal Drugs 51
Drug Discovery 36
Alzheimer's Disease Drugs 33
Pharmaceuticals 32
Musculoskeletal Disorders Drugs 29
Liver Cancer Drugs 26
Immune Disorders Drugs 24
Clinical Trials 23
Cardiovascular Drugs 21
Brain Cancer Drugs 20
Biopharmaceuticals 20
Infectious Diseases Drugs 17
Breast Cancer Drugs 16
Endocrine and Metabolic Disorders Drugs 14
Leukemia Drugs 13
Lymphoma Drugs 13
Drugs by Therapeutic Area 12
Kidney Cancer Drugs 11
Thyroid Cancer Drugs 11
Infusions and Injectables 10
Anesthetic Drugs 10
Skin Cancer Drugs 10
Hematological Drugs 9
Liver and Kidney Disorders Drugs 9
Colon Cancer Drugs 8
Analgesics 8
Lung Cancer Drugs 7
Bladder Cancer Drugs 7
Over the Counter (OTC) Drugs 7
Ovarian Cancer Drugs 6
Drug Delivery 6
Uterine Cancer Drugs 6
Vitamins and Dietary Supplements 6
Pharmaceutical Manufacturing 6
Anti-Obesity Drugs 5
Dermatological Drugs 5
Pharmaceutical Intermediates 4
Cervical Cancer Drugs 4
Respiratory Drugs 4
Company Reports 3
Optical Disorders Drugs 3
Mental Disorders Drugs 3
Prostate Cancer Drugs 2
Pancreatic Cancer Drugs 2
Sexual and Reproductive Health Drugs 2
Diabetes Drugs 1
Generic Drugs 1
Pharmacoeconomics 1
Cough and Cold Drugs 1
Biosimilars and Biosuperiors 1
Allergy Drugs 1
Urological Disorders Drugs 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

655 Results (Page 7 of 33)
- Relevance
  Sort by

Anti-Migraine Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
99 Pages
Global

From

€3500EUR$4,250USD£3,135GBP

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
700 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Memantine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
82 Pages
Global

From

€3500EUR$4,250USD£3,135GBP

Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
November 2023
100 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Advanced Renal Cell Carcinoma Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
99 Pages
Global

From

€3500EUR$4,250USD£3,135GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

 Drug Pipelines
May 2023
151 Pages
Global

From

€13230EUR$14,995USD£11,448GBP

Antibody Discovery Market Industry Trends and Global Forecasts to 2035: Distribution by Antibody Discovery Step, Antibody Discovery Method, Nature of, Type of Antibody, Therapeutic Area, End-user and Geographical Regions

 Report
June 2025
607 Pages
Global

From

€4234EUR$4,799USD£3,664GBP

Alzheimer's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
March 2023
1355 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Endometrial Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
507 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Benign Prostatic Hyperplasia (BPH) Drugs - Global Strategic Business Report

 Report
May 2026
182 Pages
Global

From

€5161EUR$5,850USD£4,466GBP

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
746 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Brain Tumor Therapeutics - Global Strategic Business Report

 Report
May 2026
182 Pages
Global

From

€4367EUR$4,950USD£3,779GBP

Craniopharyngioma Treatment Market - Global Strategic Business Report

 Report
May 2026
401 Pages
Global

From

€5161EUR$5,850USD£4,466GBP

Alzheimers Disease Therapeutics Market 2025-2029

 Report
May 2025
225 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

Alzheimer's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis 2023-2028

 Report
February 2023
244 Pages
Global

From

€3706EUR$4,200USD£3,206GBP

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2024
96 Pages
Global

From

€3500EUR$4,250USD£3,135GBP

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1036 Pages
Global

From

€2206EUR$2,500USD£1,909GBP

655 Results (Page 7 of 33)
- 1
- 5
- 6
- 7
- 8
- 9

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.